GPCR
Price
$74.92
Change
+$1.71 (+2.34%)
Updated
Feb 6 closing price
Capitalization
5.29B
46 days until earnings call
Intraday BUY SELL Signals
TERN
Price
$37.77
Change
+$2.43 (+6.88%)
Updated
Feb 6 closing price
Capitalization
4.11B
51 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GPCR vs TERN

Header iconGPCR vs TERN Comparison
Open Charts GPCR vs TERNBanner chart's image
Structure Therapeutics
Price$74.92
Change+$1.71 (+2.34%)
Volume$1.1M
Capitalization5.29B
Terns Pharmaceuticals
Price$37.77
Change+$2.43 (+6.88%)
Volume$1.76M
Capitalization4.11B
GPCR vs TERN Comparison Chart in %
GPCR
Daily Signal:
Gain/Loss:
TERN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GPCR vs. TERN commentary
Feb 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GPCR is a Hold and TERN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 09, 2026
Stock price -- (GPCR: $74.92 vs. TERN: $37.77)
Brand notoriety: GPCR and TERN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GPCR: 63% vs. TERN: 52%
Market capitalization -- GPCR: $5.29B vs. TERN: $4.11B
GPCR [@Biotechnology] is valued at $5.29B. TERN’s [@Biotechnology] market capitalization is $4.11B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GPCR’s FA Score shows that 0 FA rating(s) are green whileTERN’s FA Score has 0 green FA rating(s).

  • GPCR’s FA Score: 0 green, 5 red.
  • TERN’s FA Score: 0 green, 5 red.
According to our system of comparison, both GPCR and TERN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GPCR’s TA Score shows that 4 TA indicator(s) are bullish while TERN’s TA Score has 5 bullish TA indicator(s).

  • GPCR’s TA Score: 4 bullish, 4 bearish.
  • TERN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TERN is a better buy in the short-term than GPCR.

Price Growth

GPCR (@Biotechnology) experienced а -15.30% price change this week, while TERN (@Biotechnology) price change was +9.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

GPCR is expected to report earnings on Mar 26, 2026.

TERN is expected to report earnings on Mar 31, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GPCR($5.29B) has a higher market cap than TERN($4.11B). GPCR YTD gains are higher at: 7.721 vs. TERN (-6.510). TERN has higher annual earnings (EBITDA): -107.87M vs. GPCR (-246.42M). GPCR has more cash in the bank: 799M vs. TERN (296M). TERN has less debt than GPCR: TERN (1.03M) vs GPCR (7.09M). GPCR (0) and TERN (0) have equivalent revenues.
GPCRTERNGPCR / TERN
Capitalization5.29B4.11B129%
EBITDA-246.42M-107.87M228%
Gain YTD7.721-6.510-119%
P/E RatioN/AN/A-
Revenue00-
Total Cash799M296M270%
Total Debt7.09M1.03M689%
TECHNICAL ANALYSIS
Technical Analysis
GPCRTERN
RSI
ODDS (%)
Bearish Trend 3 days ago
75%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 7 days ago
87%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
GPCR
Daily Signal:
Gain/Loss:
TERN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FNKFX18.830.59
+3.23%
Fidelity Mid-Cap Stock K6
ABSAX23.730.62
+2.68%
American Beacon Small Cp Val A
DGVRX87.212.13
+2.50%
BNY Mellon Technology Growth I
RMFEX61.541.07
+1.77%
American Funds American Mutual R4
LSAGX22.530.16
+0.72%
Loomis Sayles Global Growth A

GPCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been closely correlated with TERN. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if GPCR jumps, then TERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
+2.34%
TERN - GPCR
84%
Closely correlated
+6.88%
PRAX - GPCR
80%
Closely correlated
+4.56%
ACET - GPCR
80%
Closely correlated
+9.16%
STRO - GPCR
79%
Closely correlated
+6.30%
ATOS - GPCR
79%
Closely correlated
+0.19%
More

TERN and

Correlation & Price change

A.I.dvisor indicates that over the last year, TERN has been closely correlated with STRO. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if TERN jumps, then STRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TERN
1D Price
Change %
TERN100%
+6.88%
STRO - TERN
89%
Closely correlated
+6.30%
ATOS - TERN
88%
Closely correlated
+0.19%
ACET - TERN
88%
Closely correlated
+9.16%
PRAX - TERN
87%
Closely correlated
+4.56%
ERAS - TERN
87%
Closely correlated
+3.45%
More